Expected Recovery in Sales and Operating Profit/Loss Under COVID-19
First written in FY2020-Q2. 10 of 18 entries say "Advanced", first in FY2022-Q1. Latest entry: 2026-10-14.
The whole theme swung hardest in 2025: 1 of 8 companies on the "Worse" side.
1 other company's latest entry also says "Softened".
- FY2026-H1AdvancedAnnual report
「Following improvements in leading KPIs, the company expects these improvements to translate into sales from the third consolidated quarter onward and will continue building the structure needed to restore profitability in the second half.」
The company expects the sales recovery to begin from the third consolidated quarter onward and is building a structure to translate improvements in leading KPIs into sales. - FY2025AdvancedAnnual report
「The company is making an early return to profitability in the next fiscal year, the fiscal year ending November 2026, its top priority, and is undertaking fundamental cost-structure reforms, including a detailed review of unprofitable costs and reductions in fixed costs.」
The previous theme of recovering sales and operating results after COVID-19 has been given concrete form through an early return to profitability in the fiscal year ending November 2026 and fundamental reform of the cost structure. - FY2024-Q1AdvancedAnnual report
「As a result, sales for the cumulative period of the first consolidated quarter amounted to ¥899.065 million, up 57.4% year on year.」
The company recorded first-quarter consolidated sales of ¥899.065 million, driven by the recovery in job-opening demand in the HR business, steady job-seeker acquisition, and higher revenue from its business restructuring and growth support business. - FY2023AdvancedAnnual report
「Sales for the consolidated fiscal year amounted to ¥2,665.054 million. This was because, in the HR business, the recovery in foot traffic and growth in inbound demand further increased hiring needs for personnel in the food-service industry. In addition, the previously challenging task of attracting job seekers recovered and remained firm.」
Against a backdrop of recovering foot traffic, inbound demand and job-seeker acquisition, the company recorded full-year consolidated sales of ¥2,665.054 million, advancing its sales recovery. - FY2023-Q2AdvancedAnnual report
「Sales for the cumulative period of the first two consolidated quarters amounted to ¥1,296.960 million. The main factor in the core HR business was that social activity was returning to pre-COVID-19 levels following the revision of mask-wearing guidelines in March and the transition in May of COVID-19 from a Class 2-equivalent disease to a Class 5 disease, the same category as seasonal influenza, while companies' hiring needs remained firm.」
Against a backdrop of normalized social activity and firm hiring demand, the company recorded sales of ¥1,296.960 million for the cumulative period of the second consolidated quarter, indicating progress in the sales recovery. - FY2023-Q1AdvancedAnnual report
「Sales for the cumulative period of the first quarter amounted to ¥571.216 million. The main factor was that, although inflation-driven price increases had an impact, companies' hiring needs remained high as social activity became more vigorous in the third year of living with COVID-19.」
Following consolidation, sales of ¥571.216 million were recorded in the first quarter, reflecting progress in the sales recovery against a backdrop of more active social activity and sustained high hiring demand. - FY2022-Q3AdvancedAnnual report
「Sales for the cumulative period of the first three quarters amounted to ¥1,127.146 million, up 56.1% year on year. Although the number of COVID-19 cases rose again, the progress of vaccinations and the absence of activity restrictions stimulated efforts to maintain social and economic activity, and economic conditions began to recover. As a result, the effective job-offers-to-applicants ratios for food preparation, customer service and serving recovered to levels comparable to those immediately before the onset of the pandemic, increasing companies' hiring needs and creating opportunities for business discussions. The acquisition of additional large-scale contract projects was also a major factor.」
The sales recovery under COVID-19 showed concrete progress, with cumulative sales of ¥1,127.146 million, up 56.1% year on year, driven by the recovery in hiring demand and the acquisition of additional large-scale contract projects. - FY2022-Q2AdvancedAnnual report
「Sales for the cumulative period of the first two quarters amounted to ¥731.765 million, up 51.1% year on year. This was mainly because the lifting on 21 March of quasi-emergency measures to prevent the spread of disease in all 18 prefectures removed restrictions on activity, leading to a recovery in consumer demand in the food-service industry during spring holidays and the Golden Week holiday period, while hiring demand for the new fiscal year remained firm.」
The sales recovery under COVID-19 showed concrete progress, with sales up 51.1% year on year against a backdrop of lifted activity restrictions, recovering consumer demand and firm hiring demand. - FY2022-Q1AdvancedAnnual report
「Sales for the cumulative period of the first quarter amounted to ¥322.843 million, up 46.4% year on year. This was mainly because, although the impact of COVID-19, including the Omicron variant, on restaurants continued, companies' hiring needs did not decline and sales were on a recovery trend.」
Despite the continuing impact of COVID-19, sales increased 46.4% year on year, indicating progress in the sales recovery. However, the company still recorded an operating loss for the quarter. - FY2021SoftenedAnnual report
「With the timing of the end of COVID-19 still unforeseeable and its impact expected to persist, we currently expect sales to recover gradually during the fiscal year ending November 2022, although we anticipate that the impact will continue throughout that fiscal year. At the same time, because we will continue for a certain period to restrain operating expenses through measures such as cost reductions and selective investment allocation, we expect operating results to recover ahead of sales.」
The company expects the impact of COVID-19 to continue during the fiscal year ending November 2022, placing the timing of the sales recovery further out. Meanwhile, it maintains its outlook for operating results to recover ahead of sales through cost reductions. - FY2021-Q1SoftenedAnnual report
「With the timing of the end of COVID-19 still unforeseeable and its impact expected to persist, we currently expect sales to recover gradually toward the second half of fiscal 2021, although we anticipate that the impact will continue throughout fiscal 2021.」
Regarding the timing of the sales recovery, the company has shifted from the previous wording, "during fiscal 2021," to "toward the second half of fiscal 2021," placing the recovery later. - FY2020RestatedAnnual report
「With the timing of the end of COVID-19 still unforeseeable and its impact expected to persist, we currently expect sales to recover gradually during fiscal 2021, although we anticipate that the impact will continue throughout fiscal 2021. At the same time, because we will continue for a certain period to restrain operating expenses through measures such as cost reductions and selective investment allocation, we expect operating results to recover ahead of sales.」
While expecting the impact of COVID-19 to continue throughout fiscal 2021, the company maintains its outlook for sales to recover gradually during the fiscal year and operating results to recover ahead of sales. - FY2020-Q3SoftenedAnnual report
「With the timing of the end of COVID-19 still unforeseeable, we currently expect sales to recover gradually from the fourth-quarter accounting period, although we anticipate that the impact will continue throughout 2021.」
The expected start of the sales recovery has shifted from the third quarter in the previous outlook to the fourth quarter, and the impact is expected to continue throughout 2021. - FY2020-Q2First statedAnnual report
「With the timing of the end of COVID-19 still unforeseeable, we currently expect sales to recover gradually from the third quarter, although we anticipate that the impact will continue throughout 2021. At the same time, because we will continue for a certain period to restrain operating expenses through measures such as cost reductions and selective investment allocation, we expect operating results to recover ahead of sales.」
The company expects sales to recover gradually from the third quarter, while the impact of COVID-19 will continue throughout 2021. It expects operating results to recover ahead of sales through cost reductions and selective investment allocation.